|
|
|
|
|
|
| Orchid gets ANDA's final nod from USFDA for Zaleplon Capsules | 18-SEP-09 |
|
| Pharma firm Orchid Chemicals & Pharmaceuticals today said it has received the final Abbreviated New Drug Application (ANDA) approval for its Zaleplon capsules from the US Food and Drug Administration, in a filing to the Bombay Stock Exchange(BSE). |
|
|
|
| Suven Life gets two more US patents for NCEs | 14-SEP-09 |
|
| Suven Life Sciences Limited, a Hyderabad-based biopharmaceutical company specialising in central nervous system (CNS) diseases, has received patents for two new chemical entities (NCEs) from the US Patent office. |
|
|
|
|
|
|
|
|
|
| Sun Pharma uses own plants for US market after after Caraco trouble | 02-AUG-09 |
|
| In spite of a major regulatory clampdown on its US subsidiary, Caraco, Mumbai-based Sun Pharmaceuticals is trying hard to keep its US market share intact. The company is relying on its own manufacturing facilities to deliver goods to the US market. All eight ANDAs (abbreviated new drug applications) for sales permission in the US filed during the first quarter of the current financial year (Q1FY2010) came from Sun’s facilities. |
|
|
|
| South likely to get Rs 2183 cr port projects | 03-JUL-09 |
|
| The shipping ministry is planning to award six port development projects worth Rs 2,183 crore in the southern states of Tamil Nadu, Kerala and Karnataka as part of its 100-day agenda programme. |
|
|
|
| AP proposes sea cruise from Vizag to Andaman | 16-JUN-09 |
|
| The Andhra Pradesh Tourism Development Corporation (APTDC) is exploring the possibility of introducing a cruise from Visakhapatnam to Andaman and Nicobar islands to attract more tourists, according to tourism minister J Geeta Reddy. |
|
|
|
|
|
|
| Monsoon hits Andamans right on schedule | 21-MAY-09 |
|
| The monsoon has set in over the entire Andaman Sea and part of south Bay of Bengal, the first entry point to Indian territorial waters, right on schedule today. |
|
|
|
|
|
|
| US approval for Glenmark cholesterol drug | 28-APR-09 |
|
| Mumbai-based Glenmark Pharmaceuticals has become the first company to get tentative approval from the US Food and Drug Administration (USFDA) to sell the generic version of Schering-Plough and MSP Singapore Company LLC’s cholesterol-lowering drug, Zetia (Ezetimibe). |
|
|
|
| Glenmark receives US FDA nod for Ezetimibe | 27-APR-09 |
|
| Drug firm Glenmark Generics Ltd today said it has received tentative approval from the US Food and Drug Administration (FDA) for the generic version of cholesterol lowering drug Ezetimibe, sold under the brand name 'Zetia' in 10 mg strength. |
|
|
|
|
|
|
Content Guide
